Dr Reddy's gets CDSCO panel nod to manufacture, market lipid-regulating agent Icosapent ethyl capsules Medical Dialogues Team6 Feb 2023 12:30 PM GMTNew Delhi: Drug major, Dr Reddy's Laboratories has got a go ahead from the Subject Expert Committee (SEC) of the Central Drug Standard Control...
Submit in vitro data and comparative data: CDSCO Tells Dr Reddy's on Icosapent Ethyl Capsule Medical Dialogues Team13 Dec 2022 12:30 PM GMTNew Delhi: Noting that the effect of Icosapentether on the risk of pancreatitis in patients with severe hypertriglyceridemia has yet to be determined,...
Icosapent ethyl lowers risk of CV events in CAD patients on statins: RESPECT-EPA trial Medha Baranwal13 Nov 2022 2:00 PM GMTJapan: Using icosapent ethyl, a purified eicosapentaenoic acid (EPA), alongside statin therapy, may reduce the risk of adverse cardiovascular events...
Icosapent ethyl modestly impacts various biomarkers linked with atherosclerotic disease: REDUCE-IT Jacinthlyn Sylvia12 July 2022 2:30 PM GMTPatients receiving mineral oil in the placebo arm of REDUCE-IT had worsening of various biomarkers linked to atherosclerotic disease during the trial,...
Icosapent Ethyl Cost-Effective Treatment Option for high-risk patients with hypertriglyceridemia MD Bureau24 Feb 2022 3:30 AM GMTThe Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial (REDUCE-IT) demonstrated the efficacy of icosapent ethyl (IPE) for...
Icosapent ethyl improves kidney function in patients with CVD and diabetes: REDUCE-IT RENAL Medha Baranwal3 Jan 2022 4:15 AM GMTUSA: Data from the REDUCE-IT RENAL trial showed that among statin-treated patients with increased triglycerides and well-controlled LDL-cholesterol,...
Adding Omega-3 based medication to statins may lower stroke risk, finds study Hina Zahid12 March 2021 3:27 PM GMTDALLAS - Taking the triglyceride-lowering medication icosapent ethyl cut the risk of stroke by an additional 36% in people at increased risk of...
Icosapent Ethyl as supportive therapy in severe COVID-19 Pneumonia, a case series report MD Bureau11 Jan 2021 4:41 AM GMTThe new strain of coronavirus, labelled severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is at the heart of an ever-growing coronavirus...
Icosapent Ethyl helps achieve coronary plaque regression in CAD: EVAPORATE trial Medha Baranwal1 Sep 2020 1:11 PM GMTUSA: Treatment of coronary atherosclerosis patients with icosapent ethyl (IPE) helped to achieve significant regression of low attenuation...
Vascepa may significantly reduce stenting or bypass surgery in high risk patients Dr. Kamal Kant Kohli15 May 2020 8:15 AM GMTA new research has revealed that in high risk patients, icosapent ethyl significantly reduces chances of stenting or bypass surgery
Icosapent ethyl may prevent thousands of cardiovascular events, predicts study Dr. Kamal Kant Kohli26 March 2020 6:00 AM GMTIrvine, CA - Researchers at the University of California, Irvine have conducted a statistical analysis that predicts more than 70,000 heart attacks,...
